Citations

Showing 10 of 108162 citations.

The addition of preoperative three-dimensional analysis alters implant choice in shoulder arthroplasty
Werner, Brian C. , Denard, Patrick J. , Tokish, John M. , Bedi, Asheesh , Donegan, Ryan P., Metcalfe, Nick, Denard, Patrick J , Dines, Joshua S.

Mayo Clinic

Shoulder & Elbow | February 2, 2021 | Volume: 14 | Issue: 4 | Pages: 378-384

10.1177/1758573221989306 | PMID 35846399 Get It

Background The primary objective of the present study was to investigate how preoperative imaging modalities including 3D computed tomography (CT) scans with preoperative planning software affect implant choice for shoulder arthroplasty. Methods X-ray, uncorrected 2D CT scans, and 3D CT scans from 21 patients undergoing primary arthroplasty were reviewed by five shoulder surgeons. Each surgeon measured glenoid version, inclination and humeral head subluxation, and then selected an anatomic or reverse shoulder arthroplasty implant based only on these imaging parameters. Each surgeon virtually positioned the implant. Agreement between surgeons and changes in plan for individual surgeons between imaging modalities were assessed. Results Average measurements of native version, inclination, and subluxation were similar across all imaging modalities with very good interobserver reliability. Overall, there was a high rate of variability in choice of implant depending on imaging modality. Agreement on implant selection between surgeons improved from 68.6% using x-ray to 80.0% with 3D CT. Introducing age added significant variability, reducing agreement on implant choice to 61.0% with 3D CT. Conclusions The use of preoperative 3D planning changes implant choice in nearly one-third of cases compared to plain radiographs and improves surgeon agreement on implant choice compared to x-ray and 2D CT. Level of evidence: III.
Addressing Anxiety and Fear during the Female Pelvic Examination
O’Laughlin, Danielle , Strelow, Brittany , Fellows, Nicole, Kelsey, Elizabeth A. , Peters, Sonya, Stevens, Joy, Tweedy, Johanna, O'Laughlin, Danielle J , Kelsey, Elizabeth , Strelow, Brittany A , Stevens, Joy

Mayo Clinic

Journal of Primary Care & Community Health | February 1, 2021 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/2150132721992195 | PMID 33525968 Get It

To review the anxiety and fear risk factors, pathophysiology, symptoms, screening and diagnosis while highlighting treatment considerations for women undergoing a pelvic examination. Methods: We reviewed the literature pertaining to anxiety and fear surrounding the pelvic examination to help guide health care providers’ on available screening options and to review options for individualized patient management. Results: Anxiety and fear are common before and during the pelvic examination. In fact, the pelvic exam is one of the most common anxiety-provoking medical procedures. This exam can provoke negative physical and emotional symptoms such as pain, discomfort, anxiety, fear, embarrassment, and irritability. These negative symptoms can interfere with preventative health screening compliance resulting in delayed or avoided care and significant health consequences. Conclusion: Assessing women for anxiety related to pelvic examinations may help decrease a delay or avoidance of examinations. Risk factor and symptom identification is also a key component in this. General anxiety questionnaires can help identify women with anxiety related to pelvic examinations. Strategies to reduce anxiety, fear and pain during a pelvic examination should routinely be implemented, particularly in women with high-risk factors or those identified with screening techniques as having anxiety, fear or pain with examinations. Treatment options should be targeted at understanding the patient’s concerns, starting conversations about pelvic examinations early, educating patient’s about the examination and offering the presence of a chaperone or support person. During an examination providers should ensure the patient is comfortable, negative phrases are avoided, the correct speculum size is utilized and proper lubrication, draping, dressing and positioning are performed. Treating underlying gynecologic or mental health conditions, consideration of cognitive behavioral therapy and complementary techniques such as lavender aromatherapy and music therapy should also be considered when appropriate.
MRS SOFIA: a multicenter retrospective study for use of Sofia for revascularization of acute ischemic stroke
Brinjikji, Waleed , Raz, Eytan , Leacy, Reade De , Meila, Dan , Samaniego, Edgar A. , Shapiro, Maksim , Bageac, Devin , Varon, Alberto , Ren, Zeguang , Rinaldo, Lorenzo , Cloft, Harry J. , De Leacy, Reade , Samaniego, Edgar A , Shapiro, Maksim , Rinaldo, Lorenzo , Mokin, Maxim

Mayo Clinic

Journal of NeuroInterventional Surgery | February 1, 2021 | Volume: 14 | Issue: 1 | Pages: neurintsurg-2020-017042

10.1136/neurintsurg-2020-017042 | PMID 33526479 Get It

Background Over the past several years there has been increased interest in the use of the Sofia aspiration system (MicroVention, Tustin, California) as a primary aspiration catheter. Objective To perform a multicenter retrospective study examining the efficacy of the Sofia aspiration catheter as a standalone aspiration treatment for large vessel occlusion. Methods Consecutive cases in which the Sofia catheter was used for aspiration thrombectomy for large vessel occlusion were included. Exclusion criteria were the following: (1) Sofia not used for first pass, and (2) a stent retriever used as an adjunct on the first pass. The primary outcome of the study was first pass recanalization (Thrombolysis in Cerebral Infarction (TICI) 2c/3). Secondary outcomes included first pass TICI 2b/3, crossover to other thrombectomy devices, number of passes, time from puncture to recanalization, and complications. Results 323 patients were included. First pass TICI 2c/3 was achieved in 49.8% of cases (161/323). First pass TICI 2b/3 was achieved in 69.7% (225/323) of cases. 74.8% had TICI 2b/3 with the Sofia alone. Crossover to other thrombectomy devices occurred in 29.1% of cases (94/323). The median number of passes was 1 (IQR=1–3). Median time from puncture to recanalization was 26 min (IQR=17–45). Procedure related complications occurred in 3.1% (10/323) of cases. Conclusion Our study highlights the potential advantage of the Sofia aspiration catheter for primary aspiration thrombectomy in acute ischemic stroke. High rates of first pass recanalization with low crossover rates to other thrombectomy devices were achieved. Median procedure time was low, as were procedural complications.
Black Women Are More Likely Than White Women to Schedule a Uterine-Sparing Treatment for Leiomyomas
Wegienka, Ganesa , Nicholson, Wanda K. , Zhang, Shuaiqi , Li, Fan , Thomas, Laine , Spies, James B. , Venable, Sateria, Laughlin-Tommaso, Shannon K., Anchan, Raymond M. , Maxwell, G. Larry , Marsh, Erica E. , Vines, Anissa I. , Jacoby, Vanessa L. , Laughlin-Tommaso, Shannon, Diamond, M P , Stewart, Elizabeth A. , Myers, Evan R. , Wise, Lauren Anne , Wallace, Kedra

Mayo Clinic

Journal of Women's Health | February 1, 2021 | Volume: 30 | Issue: 3 | Pages: 355-366

10.1089/jwh.2020.8634 | PMID 33524308 Get It

Background: To evaluate differences in the proportion of uterine fibroid (UF) treatments that are uterine-sparing between Black women and White women and identify factors that could explain disparities. Methods: Women at age 18–54 years who were enrolled from 10 clinical sites in the United States into the Comparing Options for Management: Patient-Centered Results for UFs (COMPARE-UF) treatment registry completed questionnaires before their UF procedure. UF symptoms and quality of life were assessed by questionnaires. Details on UF imaging and treatment (hysterectomy, myomectomy, or uterine artery embolization [UAE]) were collected from each patient's medical record. Random-effects logistic regression was used to assess the association between race and the odds of having a uterine-sparing procedure versus hysterectomy. Subgroup analyses compared each uterine-sparing procedure with hysterectomy. Results: In this cohort of 1141 White women and 1196 Black women, Black women tended to be younger (median 41.0 vs. 42.0 years) and report worse symptoms, pain, and function on every scale compared with White women. Black women were more likely to have had a prior UF treatment compared with White women (22.8% vs. 14.6%). White women had more hysterectomies (43.6% vs. 32.2%) and myomectomies (50.9% vs. 50.2%) versus Black women. Black women had more UAEs (15.1% vs. 4.7%) than White women. After adjusting for clinical site and other variables, Black women had greater odds than White women of having a myomectomy (odds ratio [OR] = 2.41, 95% confidence interval [CI] = 1.63–3.56) or a UAE versus hysterectomy (OR = 4.24, 95% CI = 2.41–7.46). Conclusion: In these participants, Black women were more likely to schedule a uterine-sparing UF treatment and a nonsurgical UF treatment than their White counterparts; this may not be true for all women. Longer comparative effectiveness studies are needed to inform women about the durability of UF treatments. Greater understanding of factors influencing treatment selection is needed as are studies that include women without access to tertiary care centers. Clinical Trial Registration: Clinicaltrials.gov, NCT02260752 (enrollment start: November 2015).
Presentation of calcinosis cutis 35 years after silicone nasal implant reconstruction
Antezana, Luis A. , Mohan, Anita T. , Bite, Uldis, Antezana, Luis

Mayo Clinic

BMJ Case Reports | February 1, 2021 | Volume: 14 | Issue: 2 | Pages: e239766

10.1136/bcr-2020-239766 | PMID 33526537 Get It

Incoherent Radar Imaging for Breast Cancer Detection and Experimental Validation against 3D Multimodal Breast Phantoms
Cuccaro, Antonio , Dell’Aversano, Angela , Ruvio, Giuseppe , Browne, Jacinta E. , Solimene, Raffaele , Browne, Jacinta

Mayo Clinic

Journal of Imaging | February 1, 2021 | Volume: 7 | Issue: 2 | Pages: 23

10.3390/jimaging7020023 | PMID 34460622 Get It

In this paper we consider radar approaches for breast cancer detection. The aim is to give a brief review of the main features of incoherent methods, based on beam-forming and Multiple SIgnal Classification (MUSIC) algorithms, that we have recently developed, and to compare them with classical coherent beam-forming. Those methods have the remarkable advantage of not requiring antenna characterization/compensation, which can be problematic in view of the close (to the breast) proximity set-up usually employed in breast imaging. Moreover, we proceed to an experimental validation of one of the incoherent methods, i.e., the I-MUSIC, using the multimodal breast phantom we have previously developed. While in a previous paper we focused on the phantom manufacture and characterization, here we are mainly concerned with providing the detail of the reconstruction algorithm, in particular for a new multi-step clutter rejection method that was employed and only barely described. In this regard, this contribution can be considered as a completion of our previous study. The experiments against the phantom show promising results and highlight the crucial role played by the clutter rejection procedure.
Myocarditis associated with Covid-19 disease: a systematic review of published Case reports and Case series
Rathore, Sawai Singh , Rojas, Gianpier Alonzo , Sondhi, Manush , Pothuru, Suveenkrishna , Pydi, Reshma , Kancherla, Neeraj , Ahmed, Noman Khurshid, Shah, Jill, Tousif, Sohaib , Baloch, Unaiza Tariq, Wen, Qingqing , Singh, Romil

Mayo Clinic

No container title available | February 1, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.161219538.89676033/v1 Get It

Background: Covid-19 is an extremely contagious illness caused by the severe acute respiratory syndrome (SARS-CoV-2) virus. Although this disease primarily involves pulmonary tissue, rapidly advancing research has established cardiac involvement in Covid-19 patients. Objective: This systematic review article aimed to compile and illustrate clinical characteristics, diagnostic findings, management, and outcomes manifesting in myocarditis linked with Covid-19. Methods: A literature search was accomplished for published eligible articles with MEDLINE/PubMed and Embase databases. All eligible case reports and case series were included from around the world without any language restrictions. For this review, inclusion criteria were laboratory-confirmed SARS-CoV-2 infection cases reporting a diagnosis of acute myocarditis. Results: Data from 41 studies describing myocarditis in 42 Covid-19 patients was obtained. The median age of these patients was 43.4 years, with 71.4% of them being male. Fever was the most prevalent presenting symptoms seen in 57% of patients. Hypertension was the most pervasive comorbidity accompanying these patients. Cardiac biomarkers troponin and Brain natriuretic peptide (BNP) were raised in almost 90% and 87% of patients, respectively. Electrocardiogram findings were Non-specific and included ST-segment and T-wave changes. The most prevalent histopathological feature appreciated was diffuse lymphocytic inflammatory infiltrates. Antivirals and corticosteroids were the most frequently used medications. About 38% of patients also needed vasopressor assistance. Out of 42 patients, 67% recovered, and eight died. Conclusion: Due to the risk of a sudden worsening of patients conditions and myocarditis association with considerable mortality and morbidity, a knowledge of this cardiac complication of Covid-19 disease is crucial for healthcare professionals.
Evaluating Misclassification Effects on Single Sequential Treatment in Sequential Multiple Assignment Randomized Trial (SMART) Designs
McClish, Donna K. , Sabo, Roy , He, Jun

Mayo Clinic

Statistics in Biopharmaceutical Research | February 1, 2021 | Volume: 14 | Issue: 3 | Pages: 306-313

10.1080/19466315.2021.1883472 Get It

Is Unplanned PICU Readmission a Proper Quality Indicator? A Systematic Review and Meta-analysis
Prutsky, Gabriela, Padhya, Dipti , Ahmed, Ahmed T. , Almasri, Jehad , Farah, Wigdan , Alsawas, Mouaz , Prutsky, Gabriela J, Alsawas, Mouaz , Farah, Wigdan , Prokop, Larry J. , Murad, M. Hassan

Mayo Clinic

Hospital Pediatrics | February 1, 2021 | Volume: 11 | Issue: 2 | Pages: 167-174

10.1542/hpeds.2020-0192 | PMID 33504562 Get It

CONTEXT: Unplanned PICU readmissions within 48 hours of discharge (to home or a different hospital setting) are considered a quality metric of critical care. OBJECTIVE: We sought to determine identifiable risk factors associated with early unplanned PICU readmissions. DATA SOURCES: A comprehensive search of Medline, Embase, the Cochrane Database of Systematic Reviews, and Scopus was conducted from each database’s inception to July 16, 2018. STUDY SELECTION: Observational studies of early unplanned PICU readmissions (<48 hours) in children (<18 years of age) published in any language were included. DATA EXTRACTION: Two reviewers selected and appraised studies independently and abstracted data. A meta-analysis was performed by using the random-effects model. RESULTS: We included 11 observational studies in which 128 974 children (mean age: 5 years) were evaluated. The presence of complex chronic diseases (odds ratio 2.42; 95% confidence interval 1.06 to 5.55; I2 79.90%) and moderate to severe disability (odds ratio 2.85; 95% confidence interval 2.40 to 3.40; I2 11.20%) had the highest odds of early unplanned PICU readmission. Other significant risk factors included an unplanned index admission, initial admission to a general medical ward, spring season, respiratory diagnoses, and longer initial PICU stay. Readmission was less likely after trauma- and surgery-related index admissions, after direct admission from home, or during the summer season. Modifiable risk factors, such as evening or weekend discharge, revealed no statistically significant association. Included studies were retrospective, which limited our ability to account for all potential confounders and establish causality. CONCLUSIONS: Many risk factors for early unplanned PICU readmission are not modifiable, which brings into question the usefulness of this quality measure.
Artificial Intelligence–Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device
Giudicessi, John R. , Schram, Matthew , Bos, J. Martijn , Galloway, Conner, Shreibati, Jacqueline Baras , Johnson, Patrick W. , Carter, Rickey E. , Disrud, Levi W, Kleiman, Robert , Attia, Zachi I. , Friedman, Paul A. , Albert, D.J. , Ackerman, Michael J. , Carter, Rickey E , Johnson, Patrick W , Attia, Zachi I , Bos, Johan M , Noseworthy, Peter A.

Mayo Clinic

Circulation | February 1, 2021 | Volume: 143 | Issue: 13 | Pages: 1274-1286

10.1161/circulationaha.120.050231 | PMID 33517677 Get It

Background: Heart rate–corrected QT interval (QTc) prolongation, whether secondary to drugs, genetics including congenital long QT syndrome, and/or systemic diseases including SARS-CoV-2–mediated coronavirus disease 2019 (COVID-19), can predispose to ventricular arrhythmias and sudden cardiac death. Currently, QTc assessment and monitoring relies largely on 12-lead electrocardiography. As such, we sought to train and validate an artificial intelligence (AI)–enabled 12-lead ECG algorithm to determine the QTc, and then prospectively test this algorithm on tracings acquired from a mobile ECG (mECG) device in a population enriched for repolarization abnormalities. Methods: Using >1.6 million 12-lead ECGs from 538 200 patients, a deep neural network (DNN) was derived (patients for training, n = 250 767; patients for testing, n = 107 920) and validated (n = 179 513 patients) to predict the QTc using cardiologist-overread QTc values as the “gold standard”. The ability of this DNN to detect clinically-relevant QTc prolongation (eg, QTc ≥500 ms) was then tested prospectively on 686 patients with genetic heart disease (50% with long QT syndrome) with QTc values obtained from both a 12-lead ECG and a prototype mECG device equivalent to the commercially-available AliveCor KardiaMobile 6L. Results: In the validation sample, strong agreement was observed between human over-read and DNN-predicted QTc values (−1.76±23.14 ms). Similarly, within the prospective, genetic heart disease–enriched dataset, the difference between DNN-predicted QTc values derived from mECG tracings and those annotated from 12-lead ECGs by a QT expert (−0.45±24.73 ms) and a commercial core ECG laboratory [10.52±25.64 ms] was nominal. When applied to mECG tracings, the DNN’s ability to detect a QTc value ≥500 ms yielded an area under the curve, sensitivity, and specificity of 0.97, 80.0%, and 94.4%, respectively. Conclusions: Using smartphone-enabled electrodes, an AI DNN can predict accurately the QTc of a standard 12-lead ECG. QTc estimation from an AI-enabled mECG device may provide a cost-effective means of screening for both acquired and congenital long QT syndrome in a variety of clinical settings where standard 12-lead electrocardiography is not accessible or cost-effective.